Virtus LifeSci Valuation Overview

BBC -- USA Etf  

USD 28.27  0.0014  0.005%

Virtus LifeSci Biotech has current Real Value of $27.67 per share. The regular price of the etf is $28.27. At this time the etf appears to be over valued. Macroaxis measures value of Virtus LifeSci Biotech from inspecting the etf fundamentals such as Number of Employees of 347, Net Asset of 46.79M and Price to Earning of 39.87times as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Horizon     30 Days    Login   to change
Virtus LifeSci Biotech Clinical Trls ETF is rated below average in equity positions weight as compared to similar ETFs. It is rated below average in net asset as compared to similar ETFs making up about  478,817  of Net Asset per Equity Positions Weight.

Current Market Valuation

Virtus LifeSci Biotech Valuation Boundaries

Over Valued
October 23, 2018
28.27
Market Value
27.67
Real Value
Target Odds
  
33.79
Upside
Virtus LifeSci is not too volatile asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Check also Trending Equities. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Search macroaxis.com